![Maryam S. Yazdy, MD Profile](https://pbs.twimg.com/profile_images/1843470846867787776/m1YlqItD_x96.jpg)
Maryam S. Yazdy, MD
@Maryam_Yazdy
Followers
759
Following
4K
Statuses
252
CLL/Lymphoma oncologist. Senior Physician at the FDA. All opinions are mine.
Washington, DC
Joined May 2011
Thrilled to be the clinical reviewer for this application working with my amazing colleagues at FDA. #FDA oncology #lymphoma #brentuximabvedotin #Cancer
FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma #OCENewsBurst
0
0
4
RT @oncodaily: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-cell Lymphomas - @Maryam_Yazdy
0
2
0
RT @FDAOncology: Today! Watch Conversations on Cancer: “Pazdur + 25—Celebrating a Silver FDA Anniversary,” Oct. 23, from 2 to 3 pm ET - Vir…
0
5
0
RT @FDAOncology: ASCO is now accepting applications for the October 2024 Hybrid FDA-@ASCO Fellows’ Day Workshop through August 5: https://t…
0
10
0
RT @AACR: The FDA-AACR Oncology Educational Fellowship provides early-career scientists and clinicians with an opportunity to learn more ab…
0
6
0
RT @FDAOncology: Applications for the 2024-25 FDA-@AACR Oncology Educational Fellowship are due Aug 14. Early-career cancer investigators o…
0
11
0
RT @FDAOncology: FDA Oncology Center's Project 5 in 5 crowdsourcing initiative seeks 5 clinically relevant questions for 5 pragmatic clinic…
0
2
0
RT @AACR: What is the future of multiple arm trials? Minghua Shan, Nicole Gormley, Pallavi Mishra-Lalyani, @FordePatrick, Giuseppe Giaccone…
0
3
0
@LNastoupilMD @SoniSmithMD @WomenInLymphoma @mshadman @TwoOncDocs @RoschewskiMD @MelanicjMD @sanamloghavi @MunshiPashnaMD @DrMDavids @MaurerStats @DunleavyKieron @DrKateLurain @AshAlizadeh @DrLaCasce
What is FDA Oncology's Project 5 in 5? ⏩ OCE Director Dr. Richard Pazdur explains how 𝘆𝗼𝘂 can take part in crowdsourcing to ultimately select 5 clinically relevant questions to be answered in pragmatic clinical trials. #OCEProject5in5
0
1
2